kyron.bio
Glycan engineering for therapeutic proteins.
kyron.bio uses precision glycan engineering to enhance antibody and protein therapeutics. Their platform controls glycosylation patterns to improve efficacy, safety, and manufacturability—delivering advanced biologics with better patient outcomes.
Founders
Emilia McLaughlin
Cofounder
Emilia holds a PhD in Cell and Molecular Biology from Institut Pasteur and brings over six years of experience researching evolutionarily diverse life forms. She has been awarded multiple research grants and has co-authored five scientific publications, including two as first author.
Related
2by4
2by4
Your autonomous pre-construction team.
Starting with estimates.
8x
8x
Human orchestration for business outcomes.
A&B Smart Materials
A&B Smart Materials
Biodegradable smart hydrogels for passive cooling.
A51
A51
Programmable RNA for cell modulation.
Accurx
Accurx
Powering communications in the healthcare sector.
Ackcio
Ackcio
Mesh wireless monitoring for sensors.